The Atherosclerosis Plus is a research journal that publishes research related to Medicine. This journal is published by the Elsevier Ireland Ltd. The ISSN of this journal is 26670895, 26670909. Based on the Scopus data, the SCImago Journal Rank (SJR) of atherosclerosis plus is 0.377.
Also, please check the following important details about atherosclerosis plus: Publisher, ISSN, Ranking, Indexing, Impact Factor (if applicable), Publication fee (APC), Review Time, and Acceptance Rate.
According to Clarivate's JCR, journals indexed in SCIE/SSCI have an impact factor.
The latest Impact Factor list (JCR) is released in June 2024.
The Impact Factor of Atherosclerosis Plus is 1.4.
The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times its articles are cited.
The impact factor was devised by Eugene Garfield, the founder of the Institute for Scientific Information (ISI) in Philadelphia. Impact factors began to be calculated yearly starting from 1975 for journals listed in the Journal Citation Reports (JCR). ISI was acquired by Thomson Scientific & Healthcare in 1992, and became known as Thomson ISI. In 2018, Thomson-Reuters spun off and sold ISI to Onex Corporation and Baring Private Equity Asia. They founded a new corporation, Clarivate, which is now the publisher of the JCR.
Journal Title: | Atherosclerosis Plus |
Publisher: | Elsevier Ireland Ltd |
ISSN: | 26670895, 26670909 |
Type: | journal |
Journal Scope: | Medicine |
Country: | Ireland |
H-Index: | 53 |
SJR: | 0.377 |
Quartile: | Cardiology and Cardiovascular Medicine (Q3); Internal Medicine (Q3) |
The atherosclerosis plus is indexed in:
An indexed journal means that the journal has gone through and passed a review process of certain requirements done by a journal indexer.
The Web of Science Core Collection includes the Science Citation Index Expanded (SCIE), Social Sciences Citation Index (SSCI), Arts & Humanities Citation Index (AHCI), and Emerging Sources Citation Index (ESCI).
The latest impact factor of atherosclerosis plus is 1.4 which is recently updated in June, 2024.
The impact factor (IF) is a measure of the frequency with which the average article in a journal has been cited in a particular year. It is used to measure the importance or rank of a journal by calculating the times it's articles are cited.
Note: Every year, The Clarivate releases the Journal Citation Report (JCR). The JCR provides information about academic journals including impact factor. The latest JCR was released in June, 2023. The JCR 2024 will be released in the June 2024.
The latest Quartile of atherosclerosis plus is Q3.
Each subject category of journals is divided into four quartiles: Q1, Q2, Q3, Q4. Q1 is occupied by the top 25% of journals in the list; Q2 is occupied by journals in the 25 to 50% group; Q3 is occupied by journals in the 50 to 75% group and Q4 is occupied by journals in the 75 to 100% group.
According to journal website, the publication fee of atherosclerosis plus is around 2050 USD.
The atherosclerosis plus has also Journal waiver policy (for developing countries, authors etc).
An article processing charge (APC), also known as a publication fee, is a fee which is sometimes charged to authors. Most commonly, it is involved in making a work available as open access (OA), in either a full OA journal or in a hybrid journal.
The Journal Publication Time means the average number of weeks between article submission and publication. According to the journal website, the atherosclerosis plus publishes research articles in 11 weeks on an average.
Visit to the official website of the journal/ conference to check the details about call for papers.
If your research is related to Medicine, then visit the official website of atherosclerosis plus and send your manuscript.
SIMILIAR JOURNALS
WORLD JOURNAL OF TRADITIONAL CHINESE MEDICINE
ISSN: 2311-8571AMERICAN JOURNAL OF CHINESE MEDICINE
ISSN: 0192-415XAMYLOID-JOURNAL OF PROTEIN FOLDING DISORDERS
ISSN: 1350-6129CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS
ISSN: 1084-9785CURRENT MEDICAL RESEARCH AND OPINION
ISSN: 0300-7995EUROPEAN JOURNAL OF CLINICAL INVESTIGATION
ISSN: 0014-2972INDIAN JOURNAL OF MEDICAL RESEARCH
ISSN: 0971-5916TOP RESEARCH JOURNALS